Cofertility
Series A in 2025
Cofertility is a human-centered fertility ecosystem that offers egg donation and egg-freezing services for fertility care and third-party reproduction. The platform connects women who wish to store eggs with families unable to conceive, providing a scalable model for egg donation and enabling free egg freezing when donors donate half of their eggs to another family. By matching candidates with donors, coordinating freezing and donation, Cofertility supports individuals and families throughout the fertility journey and aims to improve access to family-building options.
Ignota Labs
Seed Round in 2025
Ignota Labs is a pioneering medical technology company focused on enhancing the drug discovery process through advanced artificial intelligence methods. By utilizing deep learning and machine learning algorithms, the company aims to analyze complex molecular data to predict toxicity early in the development of pharmaceuticals. This proactive approach helps to identify harmful compounds, thereby minimizing environmental impact and waste. Ignota Labs' innovative platform not only streamlines the drug discovery process but also enhances drug safety, ultimately facilitating the timely introduction of life-changing medications to the market.
Afynia Laboratories
Seed Round in 2025
Aima Laboratories is a women's health healthcare company that provides innovative solutions to diagnostic and therapeutic difficulties. AIMA is working on the first non-invasive endometriosis diagnostic tool for the market. If you have chronic pelvic/period pain or are having difficulty becoming pregnant, you may have endometriosis.
Arda Therapeutics
Series A in 2024
Founded in 2021, Arda Therapeutics is a biotechnology company based in the San Francisco Bay Area. It specializes in developing transformative therapeutics to eliminate pathogenic cells that drive chronic diseases and aging.
VerImmune
Seed Round in 2024
VerImmune, based in Baltimore, Maryland, is an Immuno-Oncology company focused on developing innovative cancer therapies through its proprietary technology known as Anti-tumor Immune Redirection Virus-inspired Particles (AIR-ViPs). This first-in-class approach aims to harness and redirect pre-existing immune memory from pathogenic infections or childhood vaccines towards tumors. By doing so, VerImmune seeks to offer a transformative treatment option for patients with various types of cancers, especially those facing treatment resistance or limited therapeutic choices. The company's goal is to provide a low-toxicity solution that delivers durable benefits across a broad spectrum of cancer types.
Afynia Laboratories
Seed Round in 2024
Aima Laboratories is a women's health healthcare company that provides innovative solutions to diagnostic and therapeutic difficulties. AIMA is working on the first non-invasive endometriosis diagnostic tool for the market. If you have chronic pelvic/period pain or are having difficulty becoming pregnant, you may have endometriosis.
Grayce, Inc. is a health care agency based in San Francisco that specializes in providing personalized guidance and support for families caring for aging adults and children. Founded in 2019, the company offers a range of services designed to assist caregivers with various aspects of care, including insurance, finances, legal plans, medical care, home care, housing, daily needs, and overall well-being. Each member of Grayce receives dedicated support from a social worker who helps manage their comprehensive care needs by planning, prioritizing, identifying resources, coordinating care, and advocating on their behalf. Through its social care management platform, Grayce empowers family caregivers to navigate the complexities of caring for vulnerable loved ones.
OverT Bio
Seed Round in 2024
OverT Bio is a biotechnology company focused on developing cell therapies for cancer treatment. The company specializes in identifying and creating novel genetic modifications that empower immune cells to navigate and overcome the obstacles posed by tumors. Through its innovative approach, OverT Bio aims to enhance the effectiveness and durability of immunotherapies, contributing to advancements in cancer identification and treatment within the healthcare sector.
Testmate Health
Seed Round in 2024
Testmate Health is a medtech startup and award-winning spin-off of the University of Geneva in Switzerland. It has developed a smartphone-compatible platform test kit capable of diagnosing diseases based on identifiable DNA or RNA sequences without the need for a laboratory, delivering results in minutes at home. The initial product is a rapid urine self-test for the four most common sexually transmitted infections, designed to be used outside clinical settings and to provide a smartphone-scanable result that supports immediate access to treatment if needed. The platform uses DNA isothermal technology to detect infectious diseases with identifiable DNA, enabling home testing without laboratory submission. Further test kits for additional diseases are in development to empower users to monitor their health from home.
Founded in London in 2017, Limbic specializes in developing software solutions for mental health. They create AI-driven agents to assist in patient intake, triage, screening, and therapy, aiming to enhance the efficiency of healthcare providers and improve patient outcomes.
Ezra AI, Inc. is a company focused on developing artificial intelligence technology to enhance cancer detection through investigational devices. Established in 2017 and headquartered in New York, it has pioneered a novel approach to cancer screening utilizing full-body MRI technology supported by AI. The company's initial product is an FDA-cleared software designed to assist radiologists in interpreting MRI images specifically for prostate cancer. Ezra AI primarily serves customers in New York and California, aiming to improve early cancer detection and diagnosis through its innovative solutions.
Parsley Health
Venture Round in 2024
Parsley Health is a health service that integrates technology, nutrition, wellness and prevention into primary care. The company provides subscription-based, personalized healthcare that emphasizes diagnosing and addressing root causes of illness through a holistic approach. Its model combines medical consultations with health coaching, laboratory testing, digital access to records, and referrals to specialists, enabling proactive management of chronic conditions. Services include functional medicine assessments, personalized nutrition plans, stress management and lifestyle support, and access to nutraceuticals and supplements as part of care. Parsley Health operates clinics in major cities and delivers remote care through online tools and telemedicine. Founded in 2016 by Dr. Robin Berzin, the company focuses on data-driven care that supports long-term health rather than episodic treatment.
Hone Health
Venture Round in 2024
Hone Health is a digital health platform specializing in men's wellness. It provides personalized care, including licensed physician consultations, data-driven insights, and prescription medications.
Seismic Therapeutic
Series B in 2023
Seismic Therapeutic is a biotechnology company focused on advancing immunology drug development through the integration of machine learning in the biologics discovery process. Utilizing its proprietary IMPACT™ platform, Seismic Therapeutic addresses critical challenges in the development of biologics by combining machine learning with structural biology, protein engineering, and translational immunology. This innovative approach aims to create optimized therapies for patients more efficiently. The company is developing a pipeline of biologics specifically targeting adaptive immune system dysregulation to treat various autoimmune diseases.
Resistomap
Seed Round in 2023
Resistomap is a company that specializes in monitoring antibiotic resistance through data-driven laboratory services. It focuses on mitigating the spread of antibiotic resistance in the environment by offering robust monitoring tools. The company integrates expertise in molecular genetics and data science with high-throughput real-time polymerase chain reaction technology. This combination allows Resistomap to deliver comprehensive laboratory and analysis services that facilitate environmental monitoring of antibiotic resistance, aiding customers in understanding and addressing this critical public health issue.
Pair Team
Series A in 2023
Pair Team provides healthcare coordination services focused on underserved and vulnerable communities. It deploys a dedicated, tech-enabled care team—including community health workers, registered nurses, and behavioral health clinicians—to offer personalized, holistic support to Medicaid and Medicare patients and other low-income individuals facing barriers to care such as transportation, housing and food insecurity, and limited mobile access. The company acts as an extension of safety-net primary care systems, helping them deliver patient-centered care while integrating with community-based organizations. It is building a care delivery platform to standardize clinical practices, streamline administrative tasks, and enable clinicians to spend more time with patients.
Allara Health
Series A in 2023
Allara Health is a healthcare provider specializing in virtual care for women facing complex, chronic health conditions, particularly polycystic ovary syndrome (PCOS). The company offers a comprehensive program that connects patients with medical providers and registered dietitians through virtual appointments. Allara's services include holistic care, diagnostic testing, and prescriptions, along with personalized guidance on dietary and lifestyle changes. By leveraging technology, the platform enables women to efficiently manage their health, allowing for improved tracking and treatment of their conditions.
VerImmune
Seed Round in 2023
VerImmune, based in Baltimore, Maryland, is an Immuno-Oncology company focused on developing innovative cancer therapies through its proprietary technology known as Anti-tumor Immune Redirection Virus-inspired Particles (AIR-ViPs). This first-in-class approach aims to harness and redirect pre-existing immune memory from pathogenic infections or childhood vaccines towards tumors. By doing so, VerImmune seeks to offer a transformative treatment option for patients with various types of cancers, especially those facing treatment resistance or limited therapeutic choices. The company's goal is to provide a low-toxicity solution that delivers durable benefits across a broad spectrum of cancer types.
Carenostics
Seed Round in 2023
Carenostics is a health technology company that uses artificial intelligence and machine learning to address underdiagnosis, undertreatment, and health inequities in chronic disease care. Its detection models analyze data from routine patient care and integrate with provider electronic health records to identify undiagnosed chronic conditions, project disease progression, and help clinicians prioritize patients for timely intervention.
Remedial Health
Series A in 2023
Remedial Health is a company focused on enhancing the procurement and distribution of pharmaceuticals across Africa. It provides a platform that facilitates business-to-business access to medicines, enabling pharmacies and hospitals to order and access retail medications directly from manufacturers or distributors. This approach addresses the inefficiencies and risks associated with relying on open-air medicine markets, where healthcare providers often encounter counterfeit products. By improving the pharmacy operations and workflow management processes, Remedial Health aims to ensure that healthcare providers can more effectively stock their facilities, thereby contributing to a safer and more reliable healthcare environment.
Alnair Therapeutics
Pre Seed Round in 2023
Alnair Therapeutics is a preclinical stage company specializing in precision oncology, dedicated to developing innovative solutions for challenging malignancies. The company has pioneered a unique drug delivery technology that harnesses the distinctive characteristics of cancer metabolism to enhance the targeting and penetration of therapeutic agents directly into cancer cells. This approach aims to improve treatment outcomes for patients suffering from difficult-to-treat cancers, addressing a significant need in the oncology field.
SpecCheck
Seed Round in 2023
SpecCheck is an optical platform designed to enhance the efficiency of eye care specialists. It offers an all-in-one solution that facilitates accurate prescription eyewear ordering and tracking, seamless billing, and improved communication among patients, eye doctors, and lab partners. By optimizing these processes, SpecCheck enables users to work more efficiently and reduce costly errors, ultimately increasing productivity and enhancing overall workflow within the eye care industry.
Previse
Seed Round in 2023
Capsulomics, LLC is a biotechnology company focused on developing and manufacturing DNA tests for the early detection of upper gastrointestinal (GI) cancers, particularly esophageal cancer and its precancerous condition, Barrett’s esophagus. Founded in 2018 and based in Halethorpe, Maryland, Capsulomics aims to address the diagnostic and prognostic uncertainties associated with GI diseases. By providing advanced diagnostic solutions, the company enables healthcare professionals to prevent, detect, and treat these conditions more effectively, ultimately enhancing patient outcomes.
ImmuneBridge
Venture Round in 2023
ImmuneBridge develops allogeneic immunotherapies for cancer treatment. Its key innovation involves creating immune stem cells from cord blood, providing a fresh, adaptable, reliable, and abundant cellular source for immunotherapies.
One Body
Seed Round in 2023
One Body develops automation and machine learning software tailored for physical therapy clinics. Their platform streamlines healthcare insurance verification processes, saving providers time and money while increasing claim approval rates.
Juno Medical
Series A in 2022
Juno Care is a whole-family healthcare platform that provides modern open-access care for the entire family’s day-to-day needs, including pediatrics, women’s health, adult primary care, and same-day services.
The company was founded in 2020 and is based in New York, New York, United States.
Bionaut Labs
Series B in 2022
Founded in 2016, Bionaut Labs specializes in developing intra-tissue navigation platforms using micro-robots for precise anatomical targeting. Its innovative technology enables remote-controlled delivery of therapeutics to challenging clinical settings, revolutionizing the treatment of central nervous system disorders and other diseases.
Sequencing.com
Seed Round in 2022
Sequencing.com is an innovative platform that serves as the first open operating system for DNA sequencing, storage, and analysis. It provides consumers, bioinformatics developers, pharmaceutical companies, and health and wellness providers with tools to analyze genetic data from various third-party genetic tests, including those from 23andMe and Ancestry.com. The platform supports the development and marketing of over 100 DNA analysis applications, which deliver insights on personalized medicine, preventive health, and genealogy, among other areas. By allowing users to upload their DNA data, Sequencing.com offers comprehensive reports that assist in health optimization, screening for rare diseases, and assessing medication reactions. Additionally, its DNA-as-a-service model enables healthcare and wellness organizations to customize their genetic testing and analysis pipelines for a variety of purposes, facilitating better health outcomes and personalized wellness solutions.
Gabbi is a healthcare technology company that uses AI and clinical research to help women understand and proactively manage their health risks, with a focus on breast cancer risk, prevention, and early detection. The platform offers a lifetime risk assessment, personalized action plans, and virtual care options such as video appointments and chat, along with a community network that supports ongoing engagement and informed decision making.
Gameto
Venture Round in 2022
Gameto is a biotechnology company focused on advancing female reproductive health through innovative therapies. Recognizing the significant lack of treatment options in this underserved area, Gameto employs cutting-edge scientific techniques to develop solutions that enhance the quality of life for women. The company utilizes cellular engineering to create a platform that produces engineered ovarian and endometrial cell lines capable of mimicking the functions of natural cells, including hormone production and response. This platform underpins a portfolio of cellular therapeutics aimed at addressing various female reproductive diseases. Gameto's first initiative, Fertilo, targets improvements in in vitro fertilization (IVF) and egg freezing processes, striving to make them shorter, safer, and more effective. Additionally, the company is developing Deovo, an organoid model of the female reproductive system, and Ameno, a cell-based therapy designed to mitigate health issues related to primary ovarian insufficiency and menopause. Through these efforts, Gameto aims to transform the landscape of female reproductive health care.
VerImmune
Seed Round in 2022
VerImmune, based in Baltimore, Maryland, is an Immuno-Oncology company focused on developing innovative cancer therapies through its proprietary technology known as Anti-tumor Immune Redirection Virus-inspired Particles (AIR-ViPs). This first-in-class approach aims to harness and redirect pre-existing immune memory from pathogenic infections or childhood vaccines towards tumors. By doing so, VerImmune seeks to offer a transformative treatment option for patients with various types of cancers, especially those facing treatment resistance or limited therapeutic choices. The company's goal is to provide a low-toxicity solution that delivers durable benefits across a broad spectrum of cancer types.
Cartography Biosciences
Series A in 2022
Cartography Biosciences specializes in developing precision cancer immunotherapies. It employs single-cell analysis to identify novel targets for Chimeric Antigen Receptor T-cell (CAR-T) therapies, aiming to enhance safety and efficacy.
Kindly Health is a diagnostics platform focused on sexual care and performance health, catering to both men and women. The company offers comprehensive solutions for sperm health and sexual performance in men, as well as addressing issues such as low libido, polycystic ovary syndrome (PCOS), irregular periods, and menstrual pain in women. Kindly Health enhances accessibility to its services by providing at-home diagnostic tests, such as semen analyses and PCOS assessments, along with telehealth consultations and supplements. Additionally, Kindly Health has developed an AI and computer vision tool aimed at improving the embryo selection process in fertility treatments, thereby increasing the success rate of in vitro fertilization (IVF). Through these innovations, Kindly Health strives to make fertility care and sexual health solutions more affordable and accessible for patients.
Choiz is a healthcare platform that provides a personalized, end-to-end care experience delivered directly to patients at home. It covers diagnosis, prescription and delivery of medications, and ongoing remote care managed by health professionals. The platform aims to expand access to specialized treatments, including programs for hair growth, skincare, and weight loss, with regular medication supplies and continuous support without requiring in-person visits.
Torigen Pharmaceuticals
Venture Round in 2022
Founded in 2013, Torigen Pharmaceuticals specializes in developing innovative cancer care solutions for pets. Based in Farmington, Connecticut, the company focuses on advancing scientific research to bring novel approaches to companion animal cancers.
Nelly provides a tool for medical practices that digitizes patient onboarding, signatures, and payments to reduce administrative workload. The solution collects patient data via a mobile intake, enables secure e-signatures, and offers flexible payment options. It also allows documents and patient data to be transferred to a practice management system and supports sending treatment contracts by SMS or email for signature. By simplifying documentation and payments, Nelly aims to make clinic visits more efficient for both patients and staff, reducing bureaucratic burdens in healthcare.
Diligent Robotics
Series B in 2022
Diligent Robotics develops hospital service robots and related AI software to assist clinical and nursing staff with logistical tasks, enabling more time for direct patient care. Its flagship robot, Moxi, operates in hospital environments to handle routine duties and collaborate with humans, supported by AI-based software that enables safe interaction and adaptation to human workflows. Founded in 2017 and based in Austin, Texas, the company seeks to improve patient satisfaction, quality of care, and safety by augmenting healthcare teams with robotic assistance.
One Body
Pre Seed Round in 2022
One Body develops automation and machine learning software tailored for physical therapy clinics. Their platform streamlines healthcare insurance verification processes, saving providers time and money while increasing claim approval rates.
Ray studios
Pre Seed Round in 2022
Ray Studios is a Tattoo removal studio that employs hydraulic acoustic wave technology in its "Le Ray Spark" Tattoo removal treatment device.
Sonic Incytes Medical Corp
Series A in 2021
Sonic Incytes Medical Corp develops handheld ultrasound solutions for point-of-care assessment and monitoring of chronic liver diseases. It uses quantitative ultrasound and elastography with artificial intelligence to provide deeper measurements, larger tissue samples, and single-probe operation without recalibrations, enabling guidance for diagnostics and procedures. The devices assess liver stiffness, attenuation, and fat fraction to support diagnosis and management of liver health. The company was incorporated in 2012 and is based in Vancouver, Canada.
Suki develops AI-driven voice solutions for healthcare providers. Its primary product, Suki Assistant, uses artificial intelligence and natural language processing to create detailed clinical notes during or after consultations, enabling physicians to complete administrative tasks more efficiently.
CareAlign
Seed Round in 2021
CareAlign is a developer of a real-time data system that enhances the management and coordination of clinical care for clinicians. The company offers an intuitive, patient-centric task management tool that allows healthcare professionals to assign tasks, set deadlines, and categorize them based on urgency. By aggregating data from multiple sources, CareAlign provides a comprehensive and clinically intuitive display of patients' clinical status, facilitating better understanding and decision-making in patient care. This system aims to streamline workflows and improve communication among clinicians, ultimately enhancing the quality of care delivered to patients.
OxiWear
Pre Seed Round in 2021
OxiWear develops innovative ear-wearable devices specifically designed for continuous oxygen monitoring and emergency alerting, targeting patients prone to silent hypoxia due to conditions such as pulmonary hypertension, high-altitude environments, high-intensity cardio activities, and COVID-19. The company's patented pulse oximeter offers a novel approach to monitoring oxygen levels, facilitating use in both clinical and consumer settings. By providing real-time data and alerts, OxiWear's technology enhances patient safety and peace of mind, ensuring timely medical assistance when needed.
Ruth Health
Seed Round in 2021
Ruth Health is a telehealth provider specializing in women's health and prenatal care. They empower parents through evidence-based expertise, enhancing accessibility and affordability of childbirth services.
Antiva Biosciences
Series D in 2021
Antiva Biosciences, Inc. is a biopharmaceutical company based in South San Francisco, California, focused on developing antiviral therapies for human papillomavirus (HPV) infections. Established in 2012, the company aims to prevent cancer by treating precancerous lesions associated with HPV. Antiva's innovative approach includes localized therapeutics and small molecule antivirals that target HPV and other viral infections. The company is currently conducting clinical trials for high-grade anal intraepithelial neoplasias and high-grade cervical intraepithelial neoplasias. Through its medicinal chemistry platform, Antiva strives to enhance health outcomes for patients affected by HPV-related diseases and other viral infections.
Eleos Health
Seed Round in 2021
Eleos Health offers automated healthcare technology solutions. Its AI-powered Speech-to-Insights system aids clinicians in making decisions swiftly, ensuring personalized, efficient, and cost-effective patient care.
Karma Biotechnologies
Seed Round in 2021
Founded in 2019, Karma Biotechnologies is a Los Angeles-based company dedicated to developing therapies for autoimmune diseases, allergies, and food sensitivities. It specializes in antigen-specific immunotherapies using lipid nanoparticle engineering.
EIO Diagnostics
Seed Round in 2021
EIO Diagnostics Inc. is a Canadian company specializing in udder health technology for dairy farming. Founded in 2017 and based in Duncan, it develops the FirstLook Mastitis detection system, which aims to prevent mastitis infections in dairy animals. The system employs a multispectral sensor installed at the entrance of the milk parlor to capture images of the udder as cows enter, enabling early detection of infection indicators through advanced infrared image analysis and computer vision. This technology automates the screening process, allowing farmers to monitor udder health efficiently, reduce labor costs, and enhance milk quality.
Ruth Health
Pre Seed Round in 2021
Ruth Health is a telehealth provider specializing in women's health and prenatal care. They empower parents through evidence-based expertise, enhancing accessibility and affordability of childbirth services.
Protenus, Inc. is a healthcare compliance analytics company based in Baltimore, Maryland, which was founded in 2014. The company specializes in an AI-driven platform designed to audit access to patient records across health systems in the United States. Protenus' technology identifies risks such as inappropriate access to patient data and the misuse of controlled substances by healthcare staff. By automating the detection of policy violations and other anomalous behaviors, the platform supports healthcare organizations in protecting patient privacy and reducing operational risks. Protenus is recognized for its innovation and commitment to fostering safe patient outcomes while enhancing the reputation of healthcare providers. The company has received accolades such as being named one of America's Best Startup Employers by Forbes and recognized as a Great Place to Work.
Ever/Body
Series B in 2021
Ever/Body is a New York-based provider of dermatology and cosmetic treatments, focusing on demystifying the field of cosmetic dermatology. The company offers a range of services, including injectable treatments, high-tech facials, and non-surgical body treatments. These medically-tested procedures are designed to deliver optimal results, such as reducing wrinkles and enhancing overall appearance, allowing clients to achieve a more youthful and rejuvenated look. By prioritizing client preferences, Ever/Body aims to make beauty and cosmetic care accessible and effective.
Gilgamesh Pharmaceuticals
Series A in 2021
Gilgamesh Pharmaceuticals, Inc. is a preclinical biotechnology company based in New York, focused on developing innovative psychotropic drugs to address mental health issues. Founded in 2019, the company specializes in creating novel compounds that enhance the benefits of traditional psychedelics, improving parameters such as safety, tolerability, duration, and efficacy. Gilgamesh targets a range of neuropsychiatric conditions, including depression, anxiety, substance use disorders, and stress-related issues. With the growing global mental health crisis, the company aims to accelerate the development of new treatments that meet the urgent need for effective solutions in mental health care, leveraging its expertise in medicinal chemistry and drug development.
Oath Care
Seed Round in 2021
Oath Care is developing an innovative model of group-based, continuous healthcare aimed at improving health outcomes for children. The company has created an online platform that connects medical providers with families, fostering intimate connections and shared experiences among parents. This platform offers a range of support options, including group chat and one-on-one video calls, allowing patients to access both medical and emotional assistance tailored to their individual needs. By prioritizing collaboration and communication, Oath Care seeks to enhance the overall healthcare experience for the next generation.
ELANZA Wellness
Pre Seed Round in 2021
ELANZA Wellness operates a virtual chronic care platform focused on supporting individuals with reproductive health conditions, initially targeting endometriosis. The platform provides personalized treatment plans, access to medical specialists, and evidence-based therapies, aiming to improve symptom-free days.
Brave Care
Series A in 2021
Brave Care operates pediatric primary and urgent care clinics in Oregon and Texas, offering both emergency and non‑emergency services. The clinics provide treatment for common childhood conditions such as allergies, asthma, ear pain, fever, minor fractures, and urinary tract infections, as well as on‑site laboratory and X‑ray services. A team of pediatric doctors and medical professionals delivers care in a child‑friendly environment designed to reduce the stress and cost associated with emergency medicine. The company also offers a website and mobile app that give parents nationwide access to pediatric advice and support. Founded in 2019 and headquartered in Portland, Oregon, Brave Care focuses on improving access to quality pediatric care.
Plume Clinic
Series A in 2021
Plume is a health tech company for the transgender community. The company focuses on radically increasing access to care, medication, and products for the trans community, supporting a bold, authentic and healthy lifestyle. Its vision is to make gender-affirming care available to anyone until it transforms healthcare for every trans life.
Dock Health
Pre Seed Round in 2021
Dock Health is a healthcare-focused productivity platform that provides HIPAA-compliant task management and collaboration tools for clinicians and care teams. The platform aims to streamline workflows and reduce administrative burden by integrating with electronic health records and other clinical systems, enabling secure communication and coordinated care. It incorporates AI-driven insights to support decision making and operational efficiency, helping teams complete tasks more reliably and improve patient care quality. Founded in 2016, the company is headquartered in Boston, Massachusetts.
Senti Biosciences
Series B in 2021
Senti Biosciences is a biotechnology company focused on synthetic biology. It develops gene circuit platforms to engineer therapeutics, with a focus on improving precision and control in cancer treatments.
norahealth.ai
Pre Seed Round in 2021
In the next decade, expect a revolutionary redesign of healthcare for instant guidance.
Starting from joint & muscle care, Nora is the first AI knowledge assistant that delivers precise and medically sound guidance right when you need it. Leveraging a seamless fusion of conversational AI and proprietary computer vision models to automatize patient intake and physical examination, we unlock immediate guidance and care access for acute pain in less than 10 minutes.
Hey Jane
Venture Round in 2021
Hey Jane is a telehealth startup that connects patients to healthcare providers that offer online medical consultations. The company's innovative Complete Care model utilizes technology for unparalleled layers of support: medical, emotional, and social. Since 2021, Hey Jane has helped nearly 20,000 patients get the care they need. And this is only the beginning; soon, we will reimagine care for even more common but underserved treatments, with the ultimate goal of becoming the most trusted healthcare company out there—one that pushes the boundaries of access with convenient, inclusive, and patient-driven care.
Wally Health
Seed Round in 2020
Wally Health is a personalized dental care provider that offers expert-led services in the comfort of patients' homes. Founded in 2019 by Stipe Latkovic and Tyler Burnett in Boston, Massachusetts, the company leverages technology to improve dental care accessibility. Wally Health aims to connect clients with top dentists while maintaining clear and affordable pricing. By focusing on user-friendly design and enhanced engagement between patients and healthcare professionals, Wally Health strives to simplify and enhance the dental care experience for its clients.
Cerebral Inc. is a mental health telemedicine company that offers an online membership platform designed to provide accessible and affordable mental health care. Founded in 2019 and headquartered in Walnut, California, Cerebral specializes in addressing conditions such as anxiety, depression, and insomnia. The platform enables users to engage in medication management, counseling, and therapy, while also facilitating regular assessments and video appointments with care counselors. Additionally, it provides ongoing check-ins and messaging support from assigned care managers, along with prescription services and medication delivery. By employing evidence-based guidelines, Cerebral aims to improve the overall mental-emotional health of its patients, making high-quality care more accessible to a broader audience.
Included Health
Seed Round in 2020
Included Health is a healthcare company that provides a blend of virtual care, navigation, and community-based healthcare services to enhance the member experience. It combines advanced technology and a compassionate approach to deliver personalized care guidance and advocacy, ensuring that individuals receive the right care at the right time. The company's offerings include access to both virtual and in-person services for a range of healthcare needs, including urgent and primary care, behavioral health, and specialty care. By focusing on a member-centric model, Included Health aims to raise the standard of healthcare for everyone, making it simpler and more effective for individuals to navigate their health journey.
SISU Aesthetic Clinic
Series A in 2020
SISU Aesthetic Clinic operates a network of doctor-led, patient-centric medical clinics focused on delivering non-invasive aesthetic treatments. The clinic specializes in a range of personalized beauty services, including anti-wrinkle injections, lip fillers, facials, excessive sweat care, silhouette soft restoration, dermal fillers, and profile treatments. By prioritizing an empathetic approach to care, SISU aims to enhance patients' skin health and overall well-being, enabling them to lead quality lives.
Previse
Funding Round in 2020
Capsulomics, LLC is a biotechnology company focused on developing and manufacturing DNA tests for the early detection of upper gastrointestinal (GI) cancers, particularly esophageal cancer and its precancerous condition, Barrett’s esophagus. Founded in 2018 and based in Halethorpe, Maryland, Capsulomics aims to address the diagnostic and prognostic uncertainties associated with GI diseases. By providing advanced diagnostic solutions, the company enables healthcare professionals to prevent, detect, and treat these conditions more effectively, ultimately enhancing patient outcomes.
Vidya Health
Venture Round in 2020
Vidya Health is the medical technology company based in London
Phosphorus
Venture Round in 2020
Phosphorus, Inc. is a clinical genetic testing company that specializes in diagnostic kits designed to identify inherited risks for various diseases, including cancer, heart disease, and vision loss. Among its offerings are PhosphorusONE, HeartMap, and LipidMap, which focus on a range of hereditary conditions such as sudden cardiac death and high cholesterol. The company provides extensive panel-based genetic testing in areas including fertility, cardiology, oncology, and more. Phosphorus also offers a COVID-19 saliva test and Element, a software solution for managing genetic tests and clinical data. With a CLIA and CAP certified laboratory, Phosphorus ensures its tests meet high standards and are available to individuals through healthcare providers, hospitals, and directly via its online platform. Established in 2016 and headquartered in New York, with a laboratory in Secaucus, New Jersey, Phosphorus aims to make genetics integration in medicine cost-effective and accessible.
Diligent Robotics
Series A in 2020
Diligent Robotics develops hospital service robots and related AI software to assist clinical and nursing staff with logistical tasks, enabling more time for direct patient care. Its flagship robot, Moxi, operates in hospital environments to handle routine duties and collaborate with humans, supported by AI-based software that enables safe interaction and adaptation to human workflows. Founded in 2017 and based in Austin, Texas, the company seeks to improve patient satisfaction, quality of care, and safety by augmenting healthcare teams with robotic assistance.
Excision BioTherapeutics
Venture Round in 2019
Excision BioTherapeutics Inc. is a life science company based in Philadelphia, Pennsylvania, established in 2015. The company is dedicated to the development and commercialization of gene editing therapeutics aimed at treating life-threatening diseases caused by neurotropic viruses. Utilizing CRISPR-based technology, Excision BioTherapeutics focuses on creating advanced gene-editing medicines that can eradicate or disrupt viral genes in human patients. The company's mission is to advance these therapeutics into safe and effective treatments, significantly improving the lives of individuals affected by viral infections globally.
NKGen Biotech
Seed Round in 2019
NKGen Biotech, Inc. is a clinical-stage biotechnology company dedicated to the development and commercialization of innovative cell therapies utilizing activated Natural Killer (NK) cells. The company specializes in autologous and allogeneic therapies, focusing on neurodegenerative and oncological diseases. NKGen Biotech employs proprietary cell expansion and activation technologies, along with advanced manufacturing processes, to create SuperNKTM (SNK) cells, which exhibit enhanced cytotoxicity compared to traditional NK cells. These SNK cells have demonstrated increased effectiveness in preclinical studies, characterized by higher levels of cytotoxicity, cytokine production, and activating receptor expression, thereby offering promising therapeutic potential in targeting and destroying abnormal or diseased cells.
Nines is a pioneering teleradiology practice that focuses on enhancing patient care through advanced technology. The company develops in-house tools that empower radiologists to provide high-quality diagnostics. Its platform is designed to analyze medical scans for urgent findings that necessitate immediate attention, as well as to identify subtle details that assist in the radiological review process. This innovative approach aims to improve the accuracy of results and overall patient care, setting Nines apart in the field of radiology.
Parsley Health
Series B in 2019
Parsley Health is a health service that integrates technology, nutrition, wellness and prevention into primary care. The company provides subscription-based, personalized healthcare that emphasizes diagnosing and addressing root causes of illness through a holistic approach. Its model combines medical consultations with health coaching, laboratory testing, digital access to records, and referrals to specialists, enabling proactive management of chronic conditions. Services include functional medicine assessments, personalized nutrition plans, stress management and lifestyle support, and access to nutraceuticals and supplements as part of care. Parsley Health operates clinics in major cities and delivers remote care through online tools and telemedicine. Founded in 2016 by Dr. Robin Berzin, the company focuses on data-driven care that supports long-term health rather than episodic treatment.
Ophidion
Venture Round in 2019
Ophidion is a biotechnology company focused on developing therapeutics for central nervous system disorders, particularly neurodegenerative diseases such as Alzheimer's, Parkinson's, and Huntington's disease. Utilizing a Trojan horse strategy, the company exploits an endogenous receptor-mediated transport system to deliver small molecule drugs and biologics directly into the brain. Ophidion specializes in gene-silencing therapies, including oligonucleotides and small interfering ribonucleic acids (siRNAs), which can be administered intravenously. In addition to its core focus on neurodegenerative diseases, Ophidion is advancing an innovative program aimed at treating anxiety-related disorders, which includes a patented companion biomarker diagnostic to optimize patient selection for treatment. The company's platform technology is versatile, capable of delivering various classes of drugs, including macromolecules like gene therapeutics, antibodies, and peptides, positioning Ophidion at the forefront of therapeutic advancements in CNS treatment.
Osmosis is a personalized learning platform focused on enhancing health education by providing a deeper understanding of medical concepts. The platform enables clinicians and caregivers to access a wealth of educational resources, including a comprehensive library of videos and multiple-choice questions. Driven by data and technology, Osmosis aims to improve retention and preparedness for courses and exams, making it a valuable tool for medical professionals seeking to deepen their knowledge and skills in the healthcare field. By offering tailored content that goes beyond traditional lectures, Osmosis supports effective learning for a global audience in the medical community.
Ro is a telehealth company founded in New York City in 2017. It operates digital health clinics for men's and women's health, smoking cessation, and offers a vertically integrated primary care platform that provides high-quality, affordable healthcare without the need for insurance.
Ossium Health
Venture Round in 2018
Ossium Health, Inc. is a biotechnology company that specializes in developing and manufacturing advanced cell therapy products aimed at treating blood cancers, improving organ transplantation, and repairing tissue damage caused by radiation exposure. Established in 2016 and based in San Francisco, the company has created a range of therapies, including HPC, Marrow, which consists of human leukocyte antigen (HLA)-matched bone marrow stem cells for hematopoietic reconstitution in blood cancer patients. Additionally, Ossium offers Chimera, designed to enhance organ transplantation, and Chymalis, which utilizes mesenchymal stem cells from bone marrow to facilitate the healing of damaged bone and muscle tissue. The company also supplies bone marrow cells for research in oncology, immunology, and related fields, focusing on improving health and longevity through innovative bioengineering techniques.
Banyan
Venture Round in 2018
Banyan, Inc. is a digital marketing and patient engagement company based in Orem, Utah, founded in 2013. It offers a HIPAA-compliant media consent application designed to enhance the online presence of healthcare practices through social media, patient reviews, and accurate online listings. The company's primary products include a patient engagement app that allows authorized sharing of patient photos on platforms like Facebook and Instagram, as well as a review management tool that facilitates the collection and tracking of patient feedback. Banyan also provides personalized website development to strengthen the credibility of medical practices and a listing service that ensures accurate practice information across numerous online directories. Additionally, the company offers coaching to help clients build their brands, attract talent, and improve their online visibility, thereby enhancing patient acquisition and retention. As of May 2019, Banyan operates as a subsidiary of NUVI LLC.
Sonavex develops imaging technologies for vascular and surgical care, employing ultrasound to detect postoperative blood clots at the point of care and to measure intravascular flow metrics for timely decision making. It also develops bioresorbable, echogenic devices to mark at-risk vessels and to collect data on arteriovenous fistula flow, diameter, and depth at dialysis clinics to assess maturation and anticipate future complications. Based in Baltimore, Maryland, Sonavex focuses on delivering data-driven visualization of vessel health to improve surgical and dialysis patient outcomes.
Vixiar
Venture Round in 2018
Vixiar Medical, established in 2013 and headquartered in Annapolis, Maryland, specializes in developing non-invasive, cost-effective devices and systems for monitoring cardiopulmonary diseases. Its flagship product, Indicor, is a handheld point-of-care device and digital platform designed to monitor and manage worsening heart failure. Vixiar's devices aim to enhance clinical workflow and deliver economic value to the healthcare system by enabling monitoring in various settings, including homes, offices, nursing homes, and hospitals.
Excision BioTherapeutics
Seed Round in 2017
Excision BioTherapeutics Inc. is a life science company based in Philadelphia, Pennsylvania, established in 2015. The company is dedicated to the development and commercialization of gene editing therapeutics aimed at treating life-threatening diseases caused by neurotropic viruses. Utilizing CRISPR-based technology, Excision BioTherapeutics focuses on creating advanced gene-editing medicines that can eradicate or disrupt viral genes in human patients. The company's mission is to advance these therapeutics into safe and effective treatments, significantly improving the lives of individuals affected by viral infections globally.
Scene Health
Seed Round in 2015
Scene Health enhances medication adherence through its innovative video-based platform. It combines personalized coaching, education, and motivational content to engage patients, care teams, and families. The mobile app facilitates daily video check-ins with pharmacists, nurses, and health coaches, improving medication adherence for chronic and infectious diseases.
Collective Health
Series A in 2014
Collective Health provides a cloud-based health benefits platform that unifies medical, dental, vision, pharmacy, and related programs into a single administration experience, helping employers simplify benefits, guide employees in understanding and navigating care, and manage costs and outcomes. The platform offers integrated administration of all health plans through one portal, with live concierge support and digital tools to find and manage care, and connects employees with medical, pharmacy, dental, and vision providers. Headquartered in San Francisco with offices in Chicago and Lehi, it aims to reduce the administrative burden of delivering benefits while improving member experience and overall health outcomes.